Sickle Cell Disease Treatment Centers Act of 2022
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Sickle Cell Disease Treatment Centers Act of 2022
This bill directs the Department of Health and Human Services to award grants for establishing sickle cell disease treatment centers that operate using a hub-and-spoke framework to provide integrated, longitudinal health care for patients with the disease and individuals with sickle cell trait. Grant recipients must be networks comprised of (1) a hospital, clinic, or university health center; (2) at least one federally qualified health center or other health care organization that incorporates community health workers into the care team; and (3) at least one community-based organization.
Sickle cell disease is an inherited blood disorder that can lead to pain, anemia, infections, and stroke.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Introduced in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 4866: Sickle Cell Disease Treatment Centers Act of 2022. 117th Congress. Open America. https://openamerica.io/bill/117-S-4866/
"S. 4866: Sickle Cell Disease Treatment Centers Act of 2022." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-S-4866/.
S. 4866, 117th Cong. (2026), https://openamerica.io/bill/117-S-4866/.
[S. 4866: Sickle Cell Disease Treatment Centers Act of 2022](https://openamerica.io/bill/117-S-4866/)